Edgewise Therapeutics
Edgewise Therapeutics is a biopharmaceutical company that develops and commercializes small molecule therapeutics to treat musculoskeletal diseases.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Edgewise Therapeutics Information
Geographic Data
Address: 3415 Colorado Avenue
City: Boulder
State: CO
Zip: 80303
Country: US
Financial Info
Stage:
series c
Raised Last:
$95M
Raised Total:$161M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Edgewise Therapeutics is a biopharmaceutical company that develops and commercializes small molecule therapeutics to treat musculoskeletal diseases.
Contact Phone:
+13037358373
Contact Email:
Edgewise Therapeutics went public on 3/26/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
3/26/2021
IPO Valuation:
$761M
Ticker Symbol:
EWTX
IPO Price:
$16/share
Amount Raised:
$176M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2020 | Series C | 14 | $95M |
Citadel Cormorant Asset Management CureDuchenne Ventures Deerfield Janus Henderson Investors Logos Capital New Leaf Ventures Novo Holdings OrbiMed RA Capital Management Surveyor Capital U.S. Venture Partners Viking Global Investors Wellington Management Citadel Cormorant Asset Management CureDuchenne Ventures Deerfield Janus Henderson Investors Logos Capital New Leaf Ventures Novo Holdings OrbiMed RA Capital Management Surveyor Capital U.S. Venture Partners Viking Global Investors Wellington Management |
9/2022 | Post-IPO Equity | $138M | 9/2019 | Series B | 6 | $50M |
Novo Holdings U.S. Venture Partners OrbiMed New Leaf Venture Partners Deepfield CureDuchenne Ventures Novo Holdings U.S. Venture Partners |
3/2021 | IPO | $176M |
|
9/2022 | Post-IPO Equity | $120M | 8/2019 | Series B | $50M |
Novo Holdings A/S U.S. Venture Partners Deerfield Management New Leaf Venture Partners OrbiMed Advisors |
8/2018 | Series A | $15.5M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
